
OSTEOARTHRITIS
Both 2 and 3 Hylan injections more effective than placebo for knee OA
Current Therapeutic Research, March 1994 Volume 55, Issue 3, Pages 220–23280 patients with knee osteoarthritis were randomized to one of two treatment groups (a group receiving 2 intra-articular hylan injections vs. a group receiving 3 intra-articular hylan injections) or to one of two control groups (a group receiving 2 placebo injections or a group receiving 3 placebo injections). The purpose of the study was to assess the safety and efficacy of hylan injection therapy, and to compare the differences in injection schedules (2 or 3 injections). Outcomes included rate of treatment success, various VAS scores for pain and function, and global assessment score. Results found a 3 injection hyalin treatment to be significantly more effective than a 2 injection hyalin treatment and both placebo treatments for all outcome measures. A 2 injection treatment was significantly more effective than the placebo treatments for all measures except global assessment and VAS night pain score.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in


Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now